240 related articles for article (PubMed ID: 3111844)
41. Transforming growth factor-beta induces plasminogen activator inhibitor type-1 in cultured human orbital fibroblasts.
Cao HJ; Hogg MG; Martino LJ; Smith TJ
Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1411-9. PubMed ID: 7775119
[TBL] [Abstract][Full Text] [Related]
42. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells.
Arnoletti JP; Albo D; Granick MS; Solomon MP; Castiglioni A; Rothman VL; Tuszynski GP
Cancer; 1995 Sep; 76(6):998-1005. PubMed ID: 8625226
[TBL] [Abstract][Full Text] [Related]
43. Measurements of the concentration of free plasminogen activator inhibitor (PAI-1) and its complex with tissue plasminogen activator in human plasma.
Takada Y; Takada A
Thromb Res Suppl; 1988; 8():15-22. PubMed ID: 3144765
[TBL] [Abstract][Full Text] [Related]
44. Differential regulation of mesothelial cell fibrinolysis by transforming growth factor beta 1.
Falk P; Ma C; Chegini N; Holmdahl L
Scand J Clin Lab Invest; 2000 Oct; 60(6):439-47. PubMed ID: 11129059
[TBL] [Abstract][Full Text] [Related]
45. Regulation of plasminogen activator inhibitor-1 mRNA accumulation by basic fibroblast growth factor and transforming growth factor-beta1 in cultured rat astrocytes.
Treichel JA; Reddington M; Kreutzberg GW
J Neurochem; 1998 Nov; 71(5):1944-52. PubMed ID: 9798919
[TBL] [Abstract][Full Text] [Related]
46. Glucocorticoid induction of plasminogen activator and plasminogen activator-inhibitor messenger RNA in rat hepatoma cells.
Heaton JH; Gelehrter TD
Mol Endocrinol; 1989 Feb; 3(2):349-55. PubMed ID: 2469009
[TBL] [Abstract][Full Text] [Related]
47. Characterization of a plasminogen activator and its inhibitor in human mesangial cells.
Lacave R; Rondeau E; Ochi S; Delarue F; Schleuning WD; Sraer JD
Kidney Int; 1989 Mar; 35(3):806-11. PubMed ID: 2496257
[TBL] [Abstract][Full Text] [Related]
48. Cytokine modulation of plasminogen activator inhibitor-1 (PAI-1) production by human articular cartilage and chondrocytes. Down-regulation by tumor necrosis factor alpha and up-regulation by transforming growth factor-B basic fibroblast growth factor.
Campbell IK; Wojta J; Novak U; Hamilton JA
Biochim Biophys Acta; 1994 Jul; 1226(3):277-85. PubMed ID: 8054359
[TBL] [Abstract][Full Text] [Related]
49. The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells.
Saksela O; Moscatelli D; Rifkin DB
J Cell Biol; 1987 Aug; 105(2):957-63. PubMed ID: 3114269
[TBL] [Abstract][Full Text] [Related]
50. Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA.
Fukumoto S; Allan EH; Yee JA; Gelehrter TD; Martin TJ
J Cell Physiol; 1992 Aug; 152(2):346-55. PubMed ID: 1322417
[TBL] [Abstract][Full Text] [Related]
51. Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells.
Reilly CF; McFall RC
J Biol Chem; 1991 May; 266(15):9419-27. PubMed ID: 2033043
[TBL] [Abstract][Full Text] [Related]
52. Effects of cellular transformation on expression of plasminogen activator inhibitors 1 and 2. Evidence for independent regulation.
Cohen RL; Niclas J; Lee WM; Wun TC; Crowley CW; Levinson AD; Sadler JE; Shuman MA
J Biol Chem; 1989 May; 264(14):8375-83. PubMed ID: 2498314
[TBL] [Abstract][Full Text] [Related]
53. Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells.
Pöllänen J; Saksela O; Salonen EM; Andreasen P; Nielsen L; Danø K; Vaheri A
J Cell Biol; 1987 Apr; 104(4):1085-96. PubMed ID: 3104349
[TBL] [Abstract][Full Text] [Related]
54. Transforming growth factor beta alters plasminogen activator activity in human skin fibroblasts.
Laiho M; Saksela O; Keski-Oja J
Exp Cell Res; 1986 Jun; 164(2):399-407. PubMed ID: 3519251
[TBL] [Abstract][Full Text] [Related]
55. Plasminogen activator inhibitor type-1 protein, mRNA and gene transcription are increased by phorbol esters in human rhabdomyosarcoma cells.
Mayer M; Lund LR; Riccio A; Skouv J; Nielsen LS; Stacey SN; Danø K; Andreasen PA
J Biol Chem; 1988 Oct; 263(30):15688-93. PubMed ID: 3262618
[TBL] [Abstract][Full Text] [Related]
56. Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.
Hamilton JA; Piccoli DS; Leizer T; Butler DM; Croatto M; Royston AK
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7180-4. PubMed ID: 1908092
[TBL] [Abstract][Full Text] [Related]
57. Transforming growth factor beta stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts.
Roberts CJ; Birkenmeier TM; McQuillan JJ; Akiyama SK; Yamada SS; Chen WT; Yamada KM; McDonald JA
J Biol Chem; 1988 Apr; 263(10):4586-92. PubMed ID: 2965146
[TBL] [Abstract][Full Text] [Related]
58. Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells.
Hirashima Y; Kobayashi H; Suzuki M; Tanaka Y; Kanayama N; Terao T
J Biol Chem; 2003 Jul; 278(29):26793-802. PubMed ID: 12743121
[TBL] [Abstract][Full Text] [Related]
59. Cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor messenger RNAs in rat hepatoma cells.
Heaton JH; Gelehrter TD
Mol Endocrinol; 1990 Jan; 4(1):171-8. PubMed ID: 2157975
[TBL] [Abstract][Full Text] [Related]
60. Smad6s regulates plasminogen activator inhibitor-1 through a protein kinase C-beta-dependent up-regulation of transforming growth factor-beta.
Berg DT; Myers LJ; Richardson MA; Sandusky G; Grinnell BW
J Biol Chem; 2005 Apr; 280(15):14943-7. PubMed ID: 15716278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]